DCF — UCSF MEDICAL CENTER
Enterprise Value: $-5.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-5.1B
Enterprise Value
$-1.7B
PV of Cash Flows
$-3.4B
PV of Terminal Value
$-5.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $5.6B | $-272.5M | -5.0% | $-509.5M | $-463.2M |
| Year 2 | $5.8B | $-223.0M | -4.0% | $-467.1M | $-386.1M |
| Year 3 | $5.9B | $-170.3M | -3.0% | $-421.8M | $-316.9M |
| Year 4 | $6.1B | $-144.8M | -2.0% | $-403.8M | $-275.8M |
| Year 5 | $6.3B | $-133.4M | -2.0% | $-400.2M | $-248.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-5.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$5.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.05366699544362991
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5